NCT00198536View on ClinicalTrials.gov

Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Dry Eye Syndromes
Interventions
DRUG

Ecabet 2.83%

DRUG

Ecabet 3.70%

DRUG

Vehicle

Trial Locations (3)

04240

Central Maine Eye Care, Lewiston

01840

Andover Eye Associates, Andover

03820

Eyesight Ophthalmic Services, PA, Dover

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00198536 - Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome | Biotech Hunter | Biotech Hunter